scispace - formally typeset
R

Ryan Zarychanski

Researcher at University of Manitoba

Publications -  230
Citations -  12857

Ryan Zarychanski is an academic researcher from University of Manitoba. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 48, co-authored 193 publications receiving 9665 citations. Previous affiliations of Ryan Zarychanski include Winnipeg Regional Health Authority & McGill University.

Papers
More filters
Journal ArticleDOI

The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis

TL;DR: Insufficient evidence exists to recommend plasma exchange as an adjunctive therapy for patients with sepsis or septic shock, and Rigorous randomized controlled trials evaluating clinically relevant patient-centered outcomes are required.
Journal ArticleDOI

Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?

TL;DR: Anemia of chronic disease is a hypoproliferative anemia that develops in response to systemic illness or inflammation.
Journal ArticleDOI

Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis

TL;DR: In elderly adults, the high-dose influenza vaccine was well-tolerated, more immunogenic, and more efficacious in preventing influenza infections than the standard-dose vaccine.
Journal ArticleDOI

Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis

TL;DR: Current evidence supports the use of acupuncture as an alternative for traditional analgesics in patients with osteoarthritis, with significant reductions in pain intensity, improvement in functional mobility and quality of life.
Journal ArticleDOI

Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis

TL;DR: In this article, the effect of psychological and pharmacological treatments for depression and anxiety in persons with MS was evaluated using systematic review methodology from database inception until March 25, 2015, and the results showed that depression severity improved in nine psychological trials of depression treatment (N =307; standardized mean differences (SMD) and pooled using random effects meta-analysis.